Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1016/j.bjane.2013.09.013
Brazilian Journal of Anesthesiology
Scientific Article

Hyperalgesic effect of subarachnoid administration of phentolamine in mice

Efeito hiperálgico da fentolamina, por via subaracnoidea, em ratos ☆

Desiré Carlos Callegari; João Antônio Correa; Oscar César Pires; Renan Batista Corrêa Braga; Ana Flávia Marques Gimbo; Adriana Aparecida de Souza; Marta Helena Rovani Pires; Elton Constantino; Irimar de Paula Posso

http://dx.doi.org/10.1016/j.bjane.2013.09.013 Braz J Anesthesiol, vol.65, n2, p.111-116, 2015
PDF English
PDF Português
Downloads: 0
Views: 696

Abstract

BACKGROUND AND OBJECTIVES: Painful phenomenon is one of the most important and complex experiences. Phentolamine is a non-selective alpha-adrenergic antagonist. The objective of this study was to compare the effect of increasing doses of phentolamine into subarachnoid space in rats in the modulation of painful phenomenon. METHODS: 84 male Wistar rats were divided into formalin and plantar incision groups, subdivided into six subgroups (n = 7). Control group received only saline (10 µL); active subgroups received phentolamine 10 µmg (GF10), 20 mg (GF20), 30 mg (GF30), 40 mg (GF40), and 50 g (GF50). In formalin group, pain was induced by injection of 50 µL of 2% formalin in dorsal region of right posterior paw. In plantar incision group, pain was induced by plantar incision and evaluated using von Frey filaments. Induction and maintenance of anesthesia were performed with 3% halothane for catheter placement into subarachnoid space and plantar incision. Statistical analysis was performed using the JMP program from SAS with 5% significance level. RESULTS: Phentolamine at doses of 20 and 30 g increased the algesic response in the intermediate phase of the formalin test. In plantar incision test, it had hyperalgic effect on first, third, fifth, and seventh days at a dose of 10 g and on first, third, and fifth days at a dose of 20 g and on fifth day at a dose of 30 g. CONCLUSION: Subarachnoid administration of phentolamine showed hyperalgesic effect, possibly due to the involvement of different subclasses of alpha-adrenergic receptors in modulating pain pathways.

Keywords

Mice, Phentolamine, Pain, Formalin test, von Frey

Resumo

JUSTIFICATIVA E OBJETIVOS: O fenômeno doloroso é uma das mais importantes e complexas experiências. A fentolamina é antagonista alfa-adrenérgico não seletivo. O objetivo foi comparar os efeitos de doses crescentes da fentolamina, por via subaracnóidea, em ratos na modulação do fenômeno doloroso. MÉTODO: Foram usados 84 ratos Wistar machos, divididos nos grupos formalina e incisão plantar, subdivididos em seis subgrupos (n = 7). No subgrupo controle (GC) apenas salina (10 µL), nos subgrupos ativos, 10 µg de fentolamina (GF10), 20 µg (GF20), 30 µg (GF30), 40 µg (GF40) e 50 µg (GF50). No grupo formalina, a dor foi induzida com injeção de 50 µL de formalina a 2%, na região dorsal da pata posterior direita. No grupo incisão plantar, a dor foi induzida por incisão plantar e avaliação pelos filamentos de Von Frey. Indução e manutenção anestésica com halotano a 3% para introdução de cateter no espaço subaracnóideo e feitura da incisão plantar. Análise estatística dos resultados pelo programa JMP do SAS com nível de significância 5%. RESULTADOS: A fentolamina nas doses de 20 e 30 µg produziu aumento da resposta álgica na fase intermediária do teste da formalina. No teste da incisão plantar, promoveu efeito hiperálgico no primeiro, terceiro, quinto e sétimo dias na dose de 10 µg, no primeiro, terceiro e quinto dias na dose de 20 µg e no quinto dia na dose de 30 µg. CONCLUSÃO: A fentolamina por via subaracnóidea promoveu efeito hiperálgico, possivelmente pela participação de diferentes subclasses de receptores alfa-adrenérgicos nas vias modulatórias da dor.

Palavras-chave

Ratos, Fentolamina, Dor, Teste da formalina, Von Frey

References

Budai D. Neurotransmitters and receptors in the dorsal horn of the spinal cord. Acta Biol Szegediensis.. 2000;44:21-38.

Terman GW, Bonica JJ. Spinal mechanisms and their modulation. Bonica's management of pain. 2001:73-152.

Mc Pherson GA. Current trends in the study of potassium channel openers. Gen Pharmacol.. 1993;24:275-81.

Pires OC, Ashmawi H, Constantino E. Antagonistas serotoninérgico e noradrenérgico por via subaracnóidea aumentam a resposta álgica em ratos. Rev Bras Anestesiol.. 2011;61:202-10.

D'Armour FE, Smith D. A method for determining loss of pain sensation. J Pharmacol Exp Ther.. 1941;72:74-9.

Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain.. 1996;64:493-501.

Calejesan AA, Chang HC, Zhuo M. Spinal serotonergic receptors mediate of a nociceptive reflex by subcutaneous formalin injection into hindpaw in rats. Brain Res.. 1998;798:46-54.

Liu RJ, Zhang RX, Qiao JT, et al. Interrelations of opioides with monoaminas in descending inhibition of nociceptive transmission at the spinal level: an immunocytochemical study. Brain Res.. 1999;830:183-90.

Vanegas H, Schaible HG. Descending control of persistent pain: inhibitory or facilitatory?. Brain Res Rev.. 2004;46:295-309.

Mason P. Deconstructing endogenous pain modulation. J Neurophysiol.. 2005;94:1659-63.

D'Mello R, Dickenson AH. Spinal cord mechanisms of pain. Br J Anaesth.. 2008;101:8-16.

Obata H, Saito S, Sasaki M. Antiallodynic effect of inthathecally administered 5-HT2 agonists in rats with nerve ligation. Pain.. 2000;90:173-9.

Wheeler-Aceto H, Porreca F, Cowan A. The rat paw formalin test: comparison of noxious agents. Pain.. 1990;40:229-38.

Doak GJ, Sawynok J. Formalin-induced nociceptive behavior and edema: involvement of multiple peripheral 5hydroxytryptamine receptor subtypes. Neuroscience.. 1997;3:939-49.

Parada CA, Tambelli CH, Cunha FQ. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalina-induced nociception. Neuroscience.. 2001;102:937-44.

Ashmawi HA, Chambergo FS, Palmeira CCA. The effects of pirilamine and cimetidine and nociceptive flinching behavior in rats. Anesth Analg.. 2003;97:541-6.

Afonso J, Reis F. Dexmedetomidina: papel atual em anestesia e cuidados intensivos. Rev Bras Anestesiol.. 2012;62:118-33.

Nociti JR, Serzedo PSM, Zuccolotto EB. Dexmedetomidina associada a propofol em sedação durante anestesia local para cirurgia plástica. Rev Bras Anestesiol.. 2003;53:198-208.

5dd30f980e8825b03dc63493 rba Articles
Links & Downloads
2352-2291 (Electronic) 0104-0014 (Printed)
Braz J Anesthesiol ©2024 All rights reserved.

Braz J Anesthesiol

Share this page
Page Sections